Atlas Trials

A Phase IV Study of Elunate® (Fruquintinib) in Chinese Patients

Clinical trial NCT04005066 · COMPLETED

Trial details

NCT number
NCT04005066
Sponsor
Hutchmed
Status
COMPLETED
Study type
OBSERVATIONAL
Patient Safety
Start date
2019-04-20
Primary completion
2022-09-27
Enrollment
3005

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.